If a patient received tetanus immune globulin (TIG) last month, what tetanus toxoid (Td or Tdap) dosing schedule should be followed?

Tetanus Toxoid Administration After Recent TIG

If a patient received TIG last month, proceed with tetanus toxoid (Td or Tdap) vaccination according to their primary immunization status and wound characteristics—prior TIG administration does not contraindicate or delay tetanus toxoid vaccination.

Key Principle: TIG Does Not Interfere with Active Immunization

The simultaneous or recent administration of TIG does not prevent you from giving tetanus toxoid vaccines. While TIG provides immediate passive immunity, active immunization with Td/Tdap should proceed based on the patient's vaccination history, not the timing of TIG administration 1, 2.

Clinical Decision Algorithm

Step 1: Determine Primary Immunization Status

If the patient has completed primary series (≥3 doses):

• No tetanus toxoid needed if last dose was <5 years ago for high-risk wounds
• No tetanus toxoid needed if last dose was <10 years ago for clean, minor wounds
• Give Td or Tdap if these timeframes are exceeded 3, 1, 2

If the patient has incomplete or unknown vaccination history (<3 doses):

• Give tetanus toxoid NOW (preferably Tdap if never received) 3
• Complete the 3-dose primary series: second dose ≥4 weeks after first, third dose 6-12 months after second 3

Step 2: Choose Td vs Tdap

Give Tdap if:

• Patient has never received Tdap (regardless of age ≥11 years) 3
• Patient is pregnant (give during each pregnancy at 27-36 weeks) 3
• Tdap history is unknown 3

Give Td if:

• Patient has documented prior Tdap and needs routine booster 3
• Subsequent doses in primary series after initial Tdap 3

Important Caveats About TIG and Active Immunization

TIG does cause mild antibody suppression early on, but this is clinically irrelevant:

• Research shows TIG reduces geometric mean antibody titers at 4 weeks post-vaccination, but by 6-12 months there is no significant difference 4, 5
• Protective antibody levels (≥0.1 IU/mL) are achieved in >90% of patients even with simultaneous TIG administration 5
• The suppression is most notable in patients >60 years old and those with low baseline titers 4

Bottom line: This transient suppression does not compromise long-term protection and should not alter your vaccination schedule 6, 7.

Common Pitfalls to Avoid

1. Don't delay tetanus toxoid because TIG was given recently—the vaccines work through different mechanisms and both should be administered when indicated

2. Don't assume TIG provides long-term protection—TIG only provides passive immunity for 2-3 weeks; active immunization is essential for sustained protection 8

3. Don't restart the primary series—if the patient has incomplete vaccination history, continue from where they left off, regardless of time elapsed 3

4. Don't give TIG and tetanus toxoid in the same anatomical site—use separate injection sites with separate syringes 1, 2

5. Don't forget that patients with uncertain vaccination history should be treated as unvaccinated—this is especially critical in disaster settings or with immigrant populations 9

Special Consideration: Previously Immunized Patients

Even patients with documented complete vaccination can develop tetanus if immunity has waned, though disease severity is typically milder 10. The fact that this patient received TIG last month suggests either:

• Uncertain vaccination history at that time, OR
• High-risk wound requiring both active and passive immunization

Proceed with completing or updating their tetanus toxoid series based on their actual vaccination records, not the TIG administration.